Study Stopped
The protocol is determined to no longer be able to meet study objectives due to failure to enroll participants within the requisite time period.
A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder
The Mindful Pregnancy Study: A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder
2 other identifiers
interventional
1
1 country
1
Brief Summary
Thirty pregnant women with substance use disorder will be recruited to participate in eight sessions of MORE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2021
CompletedFirst Posted
Study publicly available on registry
April 1, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedResults Posted
Study results publicly available
January 16, 2024
CompletedJanuary 16, 2024
January 1, 2024
10 months
March 8, 2021
September 18, 2023
January 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Client Satisfaction
Participants will complete the Client Satisfaction Questionnaire.
8 weeks
Secondary Outcomes (1)
SUD Symptoms - Mini Neuropsychiatric Interview
8 weeks
Study Arms (1)
Mindfulness-Oriented Recovery Enhancement via tele-health
EXPERIMENTALParticipants will be assigned to 8 weeks of Mindfulness-Oriented Recovery Enhancement delivered via tele-health.
Interventions
MORE is a mindfulness-based intervention.
Eligibility Criteria
You may qualify if:
- Must be pregnant.
- Must be able to communicate in English.
- Must have met criteria for opioid use disorder in the past year.
You may not qualify if:
- None.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Montana
Missoula, Montana, 59802, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Unable to recruit the number of participants anticipated possibly due to stigma related to substance use in pregnancy, as well as challenges related to Covid-19 and the impact of the pandemic on healthcare and social service systems.
Results Point of Contact
- Title
- Dr. Sarah Reese
- Organization
- University of Montana
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Reese
University of Montana
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Social work
Study Record Dates
First Submitted
March 8, 2021
First Posted
April 1, 2021
Study Start
October 1, 2021
Primary Completion
August 1, 2022
Study Completion
August 1, 2023
Last Updated
January 16, 2024
Results First Posted
January 16, 2024
Record last verified: 2024-01